Your browser doesn't support javascript.
loading
Identification of novel GPCR partners of the central melanocortin signaling.
Li, Yunpeng; Wang, Xiaozhu; Lu, Liumei; Wang, Meng; Zhai, Yue; Tai, Xiaolu; Dilimulati, Diliqingna; Lei, Xiaowei; Xu, Jing; Zhang, Cong; Fu, Yanbin; Qu, Shen; Li, Qingfeng; Zhang, Chao.
Afiliação
  • Li Y; Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Wang X; Shanghai Key Laboratory of Signaling and Disease Research, Translational Medical Center for Stem Cell Therapy and Institute for Regenerative Medicine, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Shanghai East Hospital, Tongji University, Shanghai, China. E
  • Lu L; Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Wang M; Department of Plastic and Reconstructive Surgery, Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhai Y; Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Tai X; Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Dilimulati D; Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Lei X; Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Xu J; Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Zhang C; Department of Plastic and Reconstructive Surgery, Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Fu Y; Department of Plastic and Reconstructive Surgery, Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Qu S; Department of Endocrinology and Metabolism, National Metabolic Management Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: qushencn@hotmail.com.
  • Li Q; Department of Plastic and Reconstructive Surgery, Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: dr.liqingfeng@shsmu.edu.cn.
  • Zhang C; Department of Plastic and Reconstructive Surgery, Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: zhangchao@shsmu.edu.cn.
Mol Metab ; 53: 101317, 2021 11.
Article em En | MEDLINE | ID: mdl-34400348
ABSTRACT

OBJECTIVE:

Homo- or heterodimerization of G protein-coupled receptors (GPCRs) generally alters the normal functioning of these receptors and mediates their responses to a variety of physiological stimuli in vivo. It is well known that melanocortin-3 receptor (MC3R) and melanocortin-4 receptor (MC4R) are key regulators of appetite and energy homeostasis in the central nervous system (CNS). However, the GPCR partners of MC3R and MC4R are not well understood. Our objective is to analyze single cell RNA-seq datasets of the hypothalamus to explore and identify novel GPCR partners of MC3R and MC4R and examine the pharmacological effect on the downstream signal transduction and membrane translocation of melanocortin receptors.

METHODS:

We conducted an integrative analysis of multiple single cell RNA-seq datasets to reveal the expression pattern and correlation of GPCR families in the mouse hypothalamus. The emerging GPCRs with important metabolic functions were selected for cloning and co-immunoprecipitation validation. The positive GPCR partners were then tested for the pharmacological activation, competitive binding assay and surface translocation ELISA experiments.

RESULTS:

Based on the expression pattern of GPCRs and their function enrichment results, we narrowed down the range of potential GPCR interaction with MC3R and MC4R for further confirmation. Co-immunoprecipitation assay verified 23 and 32 novel GPCR partners that interacted with MC3R and MC4R in vitro. The presence of these GPCR partners exhibited different effects in the physiological regulation and signal transduction of MC3R and MC4R.

CONCLUSIONS:

This work represented the first large-scale screen for the functional GPCR complex of central melanocortin receptors and defined a composite metabolic regulatory GPCR network of the hypothalamic nucleuses.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptor Tipo 3 de Melanocortina / Receptor Tipo 4 de Melanocortina / Melanocortinas Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Metab Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptor Tipo 3 de Melanocortina / Receptor Tipo 4 de Melanocortina / Melanocortinas Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Metab Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China